Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice

Research output: Contribution to journalJournal articleResearchpeer-review


  1. SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies

    Research output: Contribution to journalReviewResearchpeer-review

  3. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Due to constant antigenic drift and shift, current influenza-A vaccines need to be redesigned and administered annually. A universal flu vaccine (UFV) that provides long-lasting protection against both seasonal and emerging pandemic influenza strains is thus urgently needed. The hemagglutinin (HA) stem antigen is a promising target for such a vaccine as it contains neutralizing epitopes, known to induce cross-protective IgG responses against a wide variety of influenza subtypes. In this study, we describe the development of a UFV candidate consisting of a HAstem trimer displayed on the surface of rigid capsid-like particles (CLP). Compared to soluble unconjugated HAstem trimer, the CLP-HAstem particles induced a more potent, long-lasting immune response and were able to protect mice against both homologous and heterologous H1N1 influenza challenge, even after a single dose.

Original languageEnglish
Issue number3
Publication statusPublished - 15 Jul 2020

ID: 62343880